News

Aubrey Barnett was diagnosed with a rare cancer, Burkitt lymphoma, as she started her senior year of high school. As she ...
Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.
Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that ...
Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...
Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.
Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...
Thousands took to the streets for morning protests across the area, but the largest was the evening 'No Kings' rally along ...
MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
"After my cancer diagnosis, I knew the initial assessment had missed everything. " Courtney Liniewski told Newsweek.
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...